Form 4 for AGEN AGENUS INC
Accepted 2023-10-23 00:00:00 ET · period of report 2023-10-20 · accession 0000950170-23-054523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-23 | 2023-10-20 | AGEN | ARMEN GARO H | See Remarks, Dir | A - Grant | $0.89 | +18.1K | 1.31M | +1% | +$16.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-20 | A | A | 18,142 | $0.89 | 1,309,647 | D | — | — | (F1) At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 20, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance. (F2) $0.89 is the closing price of our Common Stock on October 20, 2023, the payroll date for the pay period ending October 20, 2023. |